{"id":414528,"date":"2021-01-13T17:36:11","date_gmt":"2021-01-13T22:36:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=414528"},"modified":"2021-01-13T17:36:11","modified_gmt":"2021-01-13T22:36:11","slug":"hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/","title":{"rendered":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO, Jan.  13, 2021  (GLOBE NEWSWIRE) &#8212; Hagens Berman urges OrthoPediatrics Corp. <strong>(NASDAQ: KIDS) <\/strong>investors to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OXmlJ3irPmsmRfKqNoZ6IKrP8ojWSa18qRhdEXywAOCEscqns9e6EqDbMSluff9ojE0lDdok2EZrrdSSONJcY5kPnsEaW6tM4DpSJcd73cQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">submit<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rq8FE7bKU4as464sZyh7ZyvUwbsGMFEi05xaCdP_Vrvf_z0HLhKOPoAg628qra_GGSdt5le1mJmA8vSY0jfDsPnh29QxrPjDuKYGMyKxYAKlqxXdaGB-ogU2v3DraOcj\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"> their losses now<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xRvTA6iv-XEdQBGB0an_JdQ_C4CWMLLyP7ZOdvGviZv6MT98kbc3rVZ-z3q7wUCVv1O0OO1eSyiAMCEKuqUFHt4DwYyhXqxq3ksOxGgbDzk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">.<\/a>\u00a0\u00a0<\/p>\n<p>\n        <strong>Visit:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kJAar9mqd_t9D-Xv1kETCyzxHgkuEI86W_bDKqZRnHbWmSaJl9n7WD8NJw-4Hr9yI8xR_uqfFvq-iW0vPVLZ3KYf1gJwV0_69RkNp3TuD4s=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.hbsslaw.com<\/a><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=46F7VMHWbY_QkkgadaJ-zk5SM-4tVCITzLSUITH00xW7tSygiGqvxj5CMDSSd-LsfPHSZa2na_Al3nOWTfvXZA6GkZTm0UHrKTqrw6d3VAF8RML3Ga0jXbhz-_bMjyg6\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">\/investor-fraud\/KIDS<\/a><br \/>\n        <br \/>\n        <strong>Contact An Attorney Now:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ErAFftVv7L-F32VYcn5S8VDN6Vplocje6i0QO5NZVB9E_4tjvqeTQTRMhAx5xnizJ60_s_mPfUdjAYzxhr-PHA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">KIDS@hbsslaw.com<\/a><br \/>\n        <br \/>\n        <strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 844-916-0895<\/strong>\n      <\/p>\n<p>\n        <strong>OrthoPediatrics Corp. (KIDS) Investigation<\/strong>:<\/p>\n<p>The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory.<\/p>\n<p>In past quarters, OrthoPediatrics touted its \u201cconsistent 20% plus growth rate,\u201d which in turn has allowed the Company to maintain a valuation at 11 times annual revenues. In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors \u201cwhen products are used in procedures.\u201d<\/p>\n<p>\n        <strong>But on Dec. 2, 2020, OrthoPediatrics\u2019 growth story came into question<\/strong> when <em>Culper Research <\/em>published a scathing report concluding: (1) OrthoPediatrics \u201chas engaged in a channel stuffing scheme that has systematically and significantly overstated revenues,\u201d (2) \u201c[w]e believe that the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company,\u201d and (3) \u201cdistributors have been induced to buy excess product directly from the Company in exchange for (a) equity-based awards, (b) the opportunity to return product and\/or (c) product discounts or increased commission schedules.\u201d<\/p>\n<p>\n        <strong><br \/>\n          <em>Culper<\/em><br \/>\n        <\/strong><br \/>\n        <strong> published a follow up report on Dec. 14, 2020,<\/strong> reiterating its belief \u201cthat OrthoPediatrics is a structurally broken business which has relied on nefarious tactics to inflate its reported revenues.\u201d<\/p>\n<p>\n        <strong>Then, on Dec. 31, 2020 OrthoPediatrics announced the SEC commenced a review of the company on Dec. 15, 2020<\/strong>.<\/p>\n<p>\n        <strong>Most recently, on Jan. 13, 2021, <\/strong><br \/>\n        <strong><br \/>\n          <em>Culper<\/em><br \/>\n        <\/strong><br \/>\n        <strong> published its letter to OrthoPediatrics\u2019 auditor (Deloitte &amp; Touche) stating, in part, \u201c[w]e believe OrthoPediatrics has failed to record proper inventory write-downs and\/or establish reserves for product obsolescence.\u201d<\/strong>\n      <\/p>\n<p>\u201cWe\u2019re focused on investor losses and whether OrthoPediatrics cooked its books,\u201d said Reed Kathrein, the Hagens Berman partner leading the investigation.<\/p>\n<p>If you are an OrthoPediatrics investor, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AuDLk7QsbOPAFgf8IbgQKz9DU9XQv0OxgOKwG1ziE6SiT3kvh_eqFBmPcZrBcyr1YpYy1lX4SF7ACKqz4jk2ceukinKErefTlSXVOgTMZkFX_ek31pBT_Gql5glogsM2Z1Vka3x0golcTbi5_bSYIxu36XrSQtl9o0Kcl14Bdl0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">click here to discuss your legal rights with Hagens Berman<\/a>.<\/p>\n<p>\n        <strong>Whistleblowers: <\/strong>Persons with non-public information regarding OrthoPediatrics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <strong>844-916-0895<\/strong> or email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ErAFftVv7L-F32VYcn5S8RX-NGmHRBeh1E9RSt2q7hvK1mPkyz_-cWcTbDhA4DjH4XZmLFGNMJT4utxH3hHdNQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">KIDS@hbsslaw.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pG1WFIiL8h_x6i929xs84VGYzeVQbueszpQcHWtGtgMkgtktKWvq-cnfDTetG_zGx30QuWhFhm04EQHpqZ7peRatQwkohV3gnvaL5RV_aQY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <u>About Hagens Berman<\/u><br \/>\n        <\/a><br \/>\n        <br \/>Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qT4SMhJ4_wvzCPSe-aW1shu1lOYOS4leuzi5ypmXgwxZPXnaWt0gLyERz1YUc_yXxFJwruhkmY5N6UXUA6b44w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">hbsslaw.com<\/a>. For the latest news visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f8Einx6oAg4m_9f9k9OLyWoX3MEJKIavXXQ1JMzp0uec63JP8cdQ9Y4r4iSyIQGeAZ9f9brjJod3BtiHyBq3shUjiBSp2M3n4xldEzce83Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>newsroom<\/u><\/a> or follow us on Twitter at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QZbisfFl1lFqW7baOSKOB1T9pyrliXfxtlyYtHHczfGtE4-AOxK_BQuFhH8iCJEy_DaYSFBVFVei5u1ed1isy9jclTTHV8q4qLEIlSxzFjQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>@classactionlaw<\/u><\/a>.<\/p>\n<p>\n        <u>Contact<\/u>:<br \/>Reed Kathrein, 844-916-0895<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d57420cd-30a6-4acd-bd44-e9de92abd700\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now.\u00a0\u00a0 Visit: www.hbsslaw.com \/investor-fraud\/KIDS Contact An Attorney Now: KIDS@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 844-916-0895 OrthoPediatrics Corp. (KIDS) Investigation: The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory. In past quarters, OrthoPediatrics touted its \u201cconsistent 20% plus growth rate,\u201d which in turn has allowed the Company to maintain a valuation at 11 times annual revenues. In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors \u201cwhen products are used in procedures.\u201d But &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-414528","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now.\u00a0\u00a0 Visit: www.hbsslaw.com \/investor-fraud\/KIDS Contact An Attorney Now: KIDS@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 844-916-0895 OrthoPediatrics Corp. (KIDS) Investigation: The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory. In past quarters, OrthoPediatrics touted its \u201cconsistent 20% plus growth rate,\u201d which in turn has allowed the Company to maintain a valuation at 11 times annual revenues. In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors \u201cwhen products are used in procedures.\u201d But &hellip; Continue reading &quot;HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T22:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now\",\"datePublished\":\"2021-01-13T22:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/\"},\"wordCount\":470,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/\",\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\",\"datePublished\":\"2021-01-13T22:36:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/","og_locale":"en_US","og_type":"article","og_title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk","og_description":"SAN FRANCISCO, Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now.\u00a0\u00a0 Visit: www.hbsslaw.com \/investor-fraud\/KIDS Contact An Attorney Now: KIDS@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 \u00a0 \u00a0 844-916-0895 OrthoPediatrics Corp. (KIDS) Investigation: The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory. In past quarters, OrthoPediatrics touted its \u201cconsistent 20% plus growth rate,\u201d which in turn has allowed the Company to maintain a valuation at 11 times annual revenues. In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors \u201cwhen products are used in procedures.\u201d But &hellip; Continue reading \"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-13T22:36:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now","datePublished":"2021-01-13T22:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/"},"wordCount":470,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/","name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=","datePublished":"2021-01-13T22:36:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTYxOSMzOTE4NDQ3IzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-expands-orthopediatrics-kids-investigation-in-light-of-concurrent-sec-investigation-analysts-inventory-accounting-questions-encourages-investors-t\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst\u2019s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=414528"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414528\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=414528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=414528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=414528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}